Uv Lubi Unims 0.03% Drops

Uv Lubi Unims 0.03% Drops is an anti-malarial medication to prevent and treat malaria, a disease caused by parasites in countries where malaria is common. It works by interfering with the growth of parasites in the red blood cells of the human body. Uv Lubi Unims 0.03% Drops is also used to treat infections caused by amoebae occurring outside of the intestines, lupus erythematosus and rheumatoid arthritis. It is administered orally. Functioning of the liver and blood cell count should be checked from time to time while taking this medicine.

This medicine is not recommended in patients with the eye or ear disease and who have faced serious allergic reactions to any antimalarials in the past. Discus with your doctor the risks of taking this medication if you suffer from psoriasis, porphyria, liver disorder, alcoholism, epilepsy or other seizure disorder. It is not known if the medicine can cause harm to a baby so it is a safer option to not take this medicine during pregnancy or breastfeeding.

Common side effects include muscle problems, diarrhoea, loss of appetite, and skin rashes. Some serious side effects may include problems with vision, low blood cell levels, muscle damage and seizures.

Usual initial dosage for acute malaria and hepatic amoebiasis in adults is 600 mg, then dose is decreased to 300 mg a day. For severe malaria, 25 mg/kg should be given in several infusions over 30-32 hr. Uv Lubi Unims 0.03% Drops should be taken with food. Ensure that the course of treatment is completed before discontinuing the doses to prevent the spread of infection. The effect of this medicine can be observed in 1 to 2 hours and lasts for an average duration of 9 to 15 days

• Malaria Prophylaxis

  Uv Lubi Unims 0.03% Drops is used as prophylaxis for malaria.

• Malaria

  Uv Lubi Unims 0.03% Drops is used in the treatment of malaria characterized by muscle pain, fever with chills and fatigue.

• Amebiasis

  Uv Lubi Unims 0.03% Drops is used in the amebiasis which is a parasitic infection that affects the intestine and amebic liver abscess caused by Entamoeba histolytica.

• Allergy

  Not recommended in patients with known allergy to 4-aminoquinoline compounds.

• Retinal Or Visual Field Changes

  Not recommended in patients with any vision impairment.

• Blurred Vision

• Confusion

• Diarrhoea

• Dizziness

• Skin Rash

• Hair Loss

• Increased Sensitivity Of The Eyes To Sunlight

• How long is the duration of effect?

  The effect of this medicine lasts for an average duration of 9 to 15 days.

• What is the onset of action?

  The effect of this medicine can be observed in 1 to 2 hours.

• Are there any pregnancy warnings?

  This medicine is not recommended in pregnant women unless absolutely necessary.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  This medicine is known to excreted through breast milk. It is not recommended in for breastfeeding women.

• Missed Dose instructions

  If you miss a dose of Uv Lubi Unims 0.03% Drops, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

• Are there any overdose instructions?

  Seek emergency medical treatment or contact the doctor in case of an overdose.

Uv Lubi Unims 0.03% Drops is an antimalarial drug that works by inhibiting the enzyme heme polymerase which prevents the conversion of the toxic heme molecules to the nontoxic hemazoin, in parasites that cause malaria. The toxic heme accumulates leading to death of the parasite.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Alcohol

  Alcohol

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Interaction with Lab Test

  Lab

  Information not available.

• Interaction with Medicine

  Ethambutol

  These medicines may increase the risk of nerve damage if given together. Any symptoms of numbness, tingling or burning sensation in feet, hands should be informed to the doctor. An alternate medicine should be considered based on the clinical condition.

  Fluconazole

  These medications may increase the risk of irregular heart rhythm. Inform the doctor if you are receiving any heart medications. Close monitoring of heart function is necessary. Discontinue the treatment if you develop any symptoms of palpitations, dizziness, and difficulty in breathing.

  Tramadol

  These medications may increase the risk of seizures if taken together. Inform the doctor if you are having any history of seizures or head injury. Any symptoms of seizures should be reported to the doctor. An alternate class of medication should be considered based on the medical condition.

  Quinidine

  These medications may increase the risk of irregular heart rhythm. Inform the doctor if you are receiving any heart medications. Close monitoring of heart function is necessary. Discontinue the treatment if you develop any symptoms of palpitations, dizziness, and difficulty in breathing.

• Interaction with Disease

  Oculotoxicity

  This medicine is not recommended in patients with the eye disorder. Close monitoring of eye function is necessary. The treatment should be discontinued if any symptoms of blurred vision, difficulty in reading appear.

• Interaction with Food

  Food

  Information not available.